SCHEMBL5200669

SCHEMBL5200669

Cc1cccc(-c2[nH]c(C(C)C)nc2-c2ccc(F)c(-c3ccc(C(=O)O)cc3)c2)n1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 15/20 0.51
MAPK14 Q16539 4/20 0.39
CSNK1D P48730 1/20 0.39
CSNK1E P49674 1/20 0.39
KDR P35968 2/20 0.39
RIPK2 O43353 1/20 0.39
ACVR1B P36896 1/20 0.39
RARA P10276 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MAP3K5 Q99683 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
PDGFRA P16234 1/20 0.38
FLT1 P17948 1/20 0.38
FLT4 P35916 1/20 0.38
PRKD1 Q15139 1/20 0.38
MTOR P42345 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5199327 0.88 TGFBR1 (0.48) TGFBR1MAPK14RIPK2ACVR1BKDM4E
SCHEMBL5199625 0.85 TGFBR1 (0.43) TGFBR1MAPK14CYP1A2CYP2D6CYP2C9
SCHEMBL5199945 0.85 TGFBR1 (0.43) TGFBR1MAPK14CYP1A2CYP2D6CYP2C9
SCHEMBL5197872 0.84 TGFBR1 (0.43) TGFBR1MAPK14CYP1A2CYP2D6CYP2C9
SCHEMBL5222935 0.83 TGFBR1 (0.51) TGFBR1MAPK14CYP2D6CYP2C9CYP2C19
SCHEMBL5198128 0.83 TGFBR1 (0.50) TGFBR1MAPK14KDRRIPK2ACVR1B
SCHEMBL5198385 0.83 TGFBR1 (0.43) TGFBR1MAPK14CYP1A2CYP2D6CYP2C9
SCHEMBL5197993 0.83 TGFBR1 (0.77) TGFBR1MAPK14KDR
SCHEMBL5197598 0.83 TGFBR1 (0.57) TGFBR1MAPK14CYP2D6MTOR
SCHEMBL5199529 0.82 TGFBR1 (0.42) TGFBR1MAPK14RIPK2ACVR1BKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070275968-A1 Substituted Biphenyl Derivative SANKYO COMPANY, LIMITED (JP) 2007-11-29 US disclosed
EP-1798229-A1 SUBSTITUTED BIPHENYL DERIVATIVE Sankyo Company, Limited (JP) 2007-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275968-A1 Substituted Biphenyl Derivative COL2A1, COL1A1, FGFR3 TGFBR1 40/4885MAPK14 2998/4885CSNK1D 1819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.